- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Onychomycosis is a fungal infection of the toenails or fingernails that may involve any component of the nail unit, including the matrix, bed, or plate.
Onychomycosis (Tinea Unguium) Drug is the drug for the treatment of the disease.
According to our latest study, the global Onychomycosis (Tinea Unguium) Drug market size was valued at USD 3383.2 million in 2022 and is forecast to a readjusted size of USD 4938 million by 2029 with a CAGR of 5.6% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Onychomycosis (Tinea Unguium) Drug key players include Pfizer, J&J, Novartis, Galderma pharm, Valeant Pharma, etc. Global top five manufacturers hold a share about 35%.
North America is the largest market, with a share about 30%, followed by Europe and China both have a share over 45 percent.
In terms of product, Oral Medication is the largest segment, with a share over 70%. And in terms of application, the largest application is Age above 50, followed by Age under 18.
This report is a detailed and comprehensive analysis for global Onychomycosis (Tinea Unguium) Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Onychomycosis (Tinea Unguium) Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Onychomycosis (Tinea Unguium) Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Onychomycosis (Tinea Unguium) Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Onychomycosis (Tinea Unguium) Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Onychomycosis (Tinea Unguium) Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Onychomycosis (Tinea Unguium) Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Yangtze River, Torrent Pharma, J&J and Chengdu Brilliant, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Onychomycosis (Tinea Unguium) Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral Medication
External Medicine
Market segment by Application
Age under 18
Age 18-50
Age above 50
Market segment by players, this report covers
Pfizer
Yangtze River
Torrent Pharma
J&J
Chengdu Brilliant
Novartis
Qilu Pharmaceutical
Xiuzheng Pharmaceutical
Hubei Hengan
TARO
Perrigo
Galderma pharm
Zhejiang Deyer
Valeant Pharma
Moberg
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Onychomycosis (Tinea Unguium) Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Onychomycosis (Tinea Unguium) Drug, with revenue, gross margin and global market share of Onychomycosis (Tinea Unguium) Drug from 2018 to 2023.
Chapter 3, the Onychomycosis (Tinea Unguium) Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Onychomycosis (Tinea Unguium) Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Onychomycosis (Tinea Unguium) Drug.
Chapter 13, to describe Onychomycosis (Tinea Unguium) Drug research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Onychomycosis (Tinea Unguium) Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Onychomycosis (Tinea Unguium) Drug by Type
1.3.1 Overview: Global Onychomycosis (Tinea Unguium) Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Type in 2022
1.3.3 Oral Medication
1.3.4 External Medicine
1.4 Global Onychomycosis (Tinea Unguium) Drug Market by Application
1.4.1 Overview: Global Onychomycosis (Tinea Unguium) Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Age under 18
1.4.3 Age 18-50
1.4.4 Age above 50
1.5 Global Onychomycosis (Tinea Unguium) Drug Market Size & Forecast
1.6 Global Onychomycosis (Tinea Unguium) Drug Market Size and Forecast by Region
1.6.1 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Onychomycosis (Tinea Unguium) Drug Market Size by Region, (2018-2029)
1.6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2018-2029)
1.6.6 South America Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Onychomycosis (Tinea Unguium) Drug Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.1.4 Pfizer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments and Future Plans
2.2 Yangtze River
2.2.1 Yangtze River Details
2.2.2 Yangtze River Major Business
2.2.3 Yangtze River Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.2.4 Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Yangtze River Recent Developments and Future Plans
2.3 Torrent Pharma
2.3.1 Torrent Pharma Details
2.3.2 Torrent Pharma Major Business
2.3.3 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.3.4 Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Torrent Pharma Recent Developments and Future Plans
2.4 J&J
2.4.1 J&J Details
2.4.2 J&J Major Business
2.4.3 J&J Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.4.4 J&J Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 J&J Recent Developments and Future Plans
2.5 Chengdu Brilliant
2.5.1 Chengdu Brilliant Details
2.5.2 Chengdu Brilliant Major Business
2.5.3 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.5.4 Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Chengdu Brilliant Recent Developments and Future Plans
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business
2.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.6.4 Novartis Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Novartis Recent Developments and Future Plans
2.7 Qilu Pharmaceutical
2.7.1 Qilu Pharmaceutical Details
2.7.2 Qilu Pharmaceutical Major Business
2.7.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.7.4 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Qilu Pharmaceutical Recent Developments and Future Plans
2.8 Xiuzheng Pharmaceutical
2.8.1 Xiuzheng Pharmaceutical Details
2.8.2 Xiuzheng Pharmaceutical Major Business
2.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.8.4 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Xiuzheng Pharmaceutical Recent Developments and Future Plans
2.9 Hubei Hengan
2.9.1 Hubei Hengan Details
2.9.2 Hubei Hengan Major Business
2.9.3 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.9.4 Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Hubei Hengan Recent Developments and Future Plans
2.10 TARO
2.10.1 TARO Details
2.10.2 TARO Major Business
2.10.3 TARO Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.10.4 TARO Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 TARO Recent Developments and Future Plans
2.11 Perrigo
2.11.1 Perrigo Details
2.11.2 Perrigo Major Business
2.11.3 Perrigo Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.11.4 Perrigo Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Perrigo Recent Developments and Future Plans
2.12 Galderma pharm
2.12.1 Galderma pharm Details
2.12.2 Galderma pharm Major Business
2.12.3 Galderma pharm Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.12.4 Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Galderma pharm Recent Developments and Future Plans
2.13 Zhejiang Deyer
2.13.1 Zhejiang Deyer Details
2.13.2 Zhejiang Deyer Major Business
2.13.3 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.13.4 Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Zhejiang Deyer Recent Developments and Future Plans
2.14 Valeant Pharma
2.14.1 Valeant Pharma Details
2.14.2 Valeant Pharma Major Business
2.14.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.14.4 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Valeant Pharma Recent Developments and Future Plans
2.15 Moberg
2.15.1 Moberg Details
2.15.2 Moberg Major Business
2.15.3 Moberg Onychomycosis (Tinea Unguium) Drug Product and Solutions
2.15.4 Moberg Onychomycosis (Tinea Unguium) Drug Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Moberg Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Onychomycosis (Tinea Unguium) Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Onychomycosis (Tinea Unguium) Drug by Company Revenue
3.2.2 Top 3 Onychomycosis (Tinea Unguium) Drug Players Market Share in 2022
3.2.3 Top 6 Onychomycosis (Tinea Unguium) Drug Players Market Share in 2022
3.3 Onychomycosis (Tinea Unguium) Drug Market: Overall Company Footprint Analysis
3.3.1 Onychomycosis (Tinea Unguium) Drug Market: Region Footprint
3.3.2 Onychomycosis (Tinea Unguium) Drug Market: Company Product Type Footprint
3.3.3 Onychomycosis (Tinea Unguium) Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Onychomycosis (Tinea Unguium) Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Onychomycosis (Tinea Unguium) Drug Market Forecast by Application (2024-2029)
6 North America
6.1 North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2018-2029)
6.2 North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2018-2029)
6.3 North America Onychomycosis (Tinea Unguium) Drug Market Size by Country
6.3.1 North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2018-2029)
6.3.2 United States Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2018-2029)
7.2 Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2018-2029)
7.3 Europe Onychomycosis (Tinea Unguium) Drug Market Size by Country
7.3.1 Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
7.3.3 France Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Market Size by Region
8.3.1 Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Region (2018-2029)
8.3.2 China Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
8.3.5 India Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
9 South America
9.1 South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2018-2029)
9.2 South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2018-2029)
9.3 South America Onychomycosis (Tinea Unguium) Drug Market Size by Country
9.3.1 South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Market Size by Country
10.3.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Onychomycosis (Tinea Unguium) Drug Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Onychomycosis (Tinea Unguium) Drug Market Drivers
11.2 Onychomycosis (Tinea Unguium) Drug Market Restraints
11.3 Onychomycosis (Tinea Unguium) Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Onychomycosis (Tinea Unguium) Drug Industry Chain
12.2 Onychomycosis (Tinea Unguium) Drug Upstream Analysis
12.3 Onychomycosis (Tinea Unguium) Drug Midstream Analysis
12.4 Onychomycosis (Tinea Unguium) Drug Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Onychomycosis (Tinea Unguium) Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Onychomycosis (Tinea Unguium) Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Onychomycosis (Tinea Unguium) Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Onychomycosis (Tinea Unguium) Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Pfizer Company Information, Head Office, and Major Competitors
Table 6. Pfizer Major Business
Table 7. Pfizer Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 8. Pfizer Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Pfizer Recent Developments and Future Plans
Table 10. Yangtze River Company Information, Head Office, and Major Competitors
Table 11. Yangtze River Major Business
Table 12. Yangtze River Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 13. Yangtze River Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Yangtze River Recent Developments and Future Plans
Table 15. Torrent Pharma Company Information, Head Office, and Major Competitors
Table 16. Torrent Pharma Major Business
Table 17. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 18. Torrent Pharma Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Torrent Pharma Recent Developments and Future Plans
Table 20. J&J Company Information, Head Office, and Major Competitors
Table 21. J&J Major Business
Table 22. J&J Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 23. J&J Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. J&J Recent Developments and Future Plans
Table 25. Chengdu Brilliant Company Information, Head Office, and Major Competitors
Table 26. Chengdu Brilliant Major Business
Table 27. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 28. Chengdu Brilliant Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Chengdu Brilliant Recent Developments and Future Plans
Table 30. Novartis Company Information, Head Office, and Major Competitors
Table 31. Novartis Major Business
Table 32. Novartis Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 33. Novartis Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Novartis Recent Developments and Future Plans
Table 35. Qilu Pharmaceutical Company Information, Head Office, and Major Competitors
Table 36. Qilu Pharmaceutical Major Business
Table 37. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 38. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Qilu Pharmaceutical Recent Developments and Future Plans
Table 40. Xiuzheng Pharmaceutical Company Information, Head Office, and Major Competitors
Table 41. Xiuzheng Pharmaceutical Major Business
Table 42. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 43. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Xiuzheng Pharmaceutical Recent Developments and Future Plans
Table 45. Hubei Hengan Company Information, Head Office, and Major Competitors
Table 46. Hubei Hengan Major Business
Table 47. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 48. Hubei Hengan Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Hubei Hengan Recent Developments and Future Plans
Table 50. TARO Company Information, Head Office, and Major Competitors
Table 51. TARO Major Business
Table 52. TARO Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 53. TARO Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. TARO Recent Developments and Future Plans
Table 55. Perrigo Company Information, Head Office, and Major Competitors
Table 56. Perrigo Major Business
Table 57. Perrigo Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 58. Perrigo Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Perrigo Recent Developments and Future Plans
Table 60. Galderma pharm Company Information, Head Office, and Major Competitors
Table 61. Galderma pharm Major Business
Table 62. Galderma pharm Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 63. Galderma pharm Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Galderma pharm Recent Developments and Future Plans
Table 65. Zhejiang Deyer Company Information, Head Office, and Major Competitors
Table 66. Zhejiang Deyer Major Business
Table 67. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 68. Zhejiang Deyer Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Zhejiang Deyer Recent Developments and Future Plans
Table 70. Valeant Pharma Company Information, Head Office, and Major Competitors
Table 71. Valeant Pharma Major Business
Table 72. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 73. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Valeant Pharma Recent Developments and Future Plans
Table 75. Moberg Company Information, Head Office, and Major Competitors
Table 76. Moberg Major Business
Table 77. Moberg Onychomycosis (Tinea Unguium) Drug Product and Solutions
Table 78. Moberg Onychomycosis (Tinea Unguium) Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Moberg Recent Developments and Future Plans
Table 80. Global Onychomycosis (Tinea Unguium) Drug Revenue (USD Million) by Players (2018-2023)
Table 81. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Players (2018-2023)
Table 82. Breakdown of Onychomycosis (Tinea Unguium) Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 83. Market Position of Players in Onychomycosis (Tinea Unguium) Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 84. Head Office of Key Onychomycosis (Tinea Unguium) Drug Players
Table 85. Onychomycosis (Tinea Unguium) Drug Market: Company Product Type Footprint
Table 86. Onychomycosis (Tinea Unguium) Drug Market: Company Product Application Footprint
Table 87. Onychomycosis (Tinea Unguium) Drug New Market Entrants and Barriers to Market Entry
Table 88. Onychomycosis (Tinea Unguium) Drug Mergers, Acquisition, Agreements, and Collaborations
Table 89. Global Onychomycosis (Tinea Unguium) Drug Consumption Value (USD Million) by Type (2018-2023)
Table 90. Global Onychomycosis (Tinea Unguium) Drug Consumption Value Share by Type (2018-2023)
Table 91. Global Onychomycosis (Tinea Unguium) Drug Consumption Value Forecast by Type (2024-2029)
Table 92. Global Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2018-2023)
Table 93. Global Onychomycosis (Tinea Unguium) Drug Consumption Value Forecast by Application (2024-2029)
Table 94. North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 95. North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 96. North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 97. North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 98. North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 99. North America Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 100. Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 103. Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 104. Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 107. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 108. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 109. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 110. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 111. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 112. South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 113. South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 114. South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 115. South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 116. South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 117. South America Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 119. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 120. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 121. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 122. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 123. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 124. Onychomycosis (Tinea Unguium) Drug Raw Material
Table 125. Key Suppliers of Onychomycosis (Tinea Unguium) Drug Raw Materials
List of Figures
Figure 1. Onychomycosis (Tinea Unguium) Drug Picture
Figure 2. Global Onychomycosis (Tinea Unguium) Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Type in 2022
Figure 4. Oral Medication
Figure 5. External Medicine
Figure 6. Global Onychomycosis (Tinea Unguium) Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Application in 2022
Figure 8. Age under 18 Picture
Figure 9. Age 18-50 Picture
Figure 10. Age above 50 Picture
Figure 11. Global Onychomycosis (Tinea Unguium) Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Onychomycosis (Tinea Unguium) Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Region in 2022
Figure 16. North America Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Onychomycosis (Tinea Unguium) Drug Revenue Share by Players in 2022
Figure 22. Onychomycosis (Tinea Unguium) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Onychomycosis (Tinea Unguium) Drug Market Share in 2022
Figure 24. Global Top 6 Players Onychomycosis (Tinea Unguium) Drug Market Share in 2022
Figure 25. Global Onychomycosis (Tinea Unguium) Drug Consumption Value Share by Type (2018-2023)
Figure 26. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Type (2024-2029)
Figure 27. Global Onychomycosis (Tinea Unguium) Drug Consumption Value Share by Application (2018-2023)
Figure 28. Global Onychomycosis (Tinea Unguium) Drug Market Share Forecast by Application (2024-2029)
Figure 29. North America Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 39. France Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Region (2018-2029)
Figure 46. China Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 49. India Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Onychomycosis (Tinea Unguium) Drug Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Onychomycosis (Tinea Unguium) Drug Consumption Value (2018-2029) & (USD Million)
Figure 63. Onychomycosis (Tinea Unguium) Drug Market Drivers
Figure 64. Onychomycosis (Tinea Unguium) Drug Market Restraints
Figure 65. Onychomycosis (Tinea Unguium) Drug Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Onychomycosis (Tinea Unguium) Drug in 2022
Figure 68. Manufacturing Process Analysis of Onychomycosis (Tinea Unguium) Drug
Figure 69. Onychomycosis (Tinea Unguium) Drug Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
